RBC Capital Maintains Outperform on Pharvaris, Lowers Price Target to $51

Benzinga Newsdesk www.benzinga.com Negative 94.6%

Neg 94.6% Neu 0% Pos 0%

RBC Capital analyst Brian Abrahams maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $52 to $51.